This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.
Acta gastro-enterologica Belgica, 89(1), 13-24
Citation
Lazarenko, I; Mileva, M; Manta, R; Kristanto, P; Hendlisz, A; Van Laethem, J L; Wimana, Z; Artigas, C; Flamen, P; Karfis, I. (2026). Real-World Outcomes of [177Lu]Lu-DOTA-TATE Peptide Receptor Radionuclide Therapy in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors: Data from a Belgian ENETS Center of Excellence.. Acta gastro-enterologica Belgica, 89(1), 13-24. https://doi.org/10.51821/89.1.14882